Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.
Explore and learn more about Conference Series Ltd: World’s leading Event Organizer
Omics International publishes 304 Open Access Articles in 13 International Journals it has 32 Upcoming Conferences and 15 Previous Conferences with 581 Conference Proceedings and 92 National symposiums so far in the field.
Global stress statistics state that, In USA, 75% of adults continue to report moderate to high levels of stress and 10-15% of population remains depressed at any given time of the year. 80% of workers feel stress on job. Nearly 60% Chinese employees feel stress at workplace with the highest rise of 86%. Alarmingly 91% of Australians feel stress in at least one important aspect of their lives that costs approximately $14.2 billion to Australian economy. In 2007/08, an estimated 442,000 individuals in Britain experienced work-related stress that cost £28.3 billion per year. According to the Fourth European Working Conditions Survey, stress was experienced by approximately 22% of workers from European Union. The highest level of stress was reported in Greece (55%), and then in Slovenia, Sweden (38%), and Latvia (37%). Lowest stress levels were noted in the United Kingdom (12%), Germany, Ireland, and Netherlands (16%). In Czech Republic (17%), and in France and Bulgaria (18%).
Medications are an easy way to combat anxiety and stress and are designed specifically to provide near-instant relief from stress symptoms. Anti-Anxiety drug, Buspirone (Buspar) is a popular one, as it is considered one of the weakest on the market but also has the fewest side effects. Buspar is one of the few that is only an anxiolytic as well, so it's unlikely to cause fatigue, personality changes, etc. All it does is reduce anxiety. Benzodiazepines tend to cause a bit too much fatigue, and the addiction risk is pretty strong. Instead, you'll likely be prescribed antidepressants, the most common being selective serotonin reuptake inhibitors, or SSRIs. Prozac is one of the most well-known SSRIs available, and others include Paxil, Effexor, and Vanatrip. SSRIs - and all antidepressants - can in some cases have terrible reactions, including an increased risk for anxiety and depression. That's the reason that it's important not take these medications until you're certain you need them.
OMICS International through its Open access initiatives is committed to make genuine and reliable contributions to the scientific community by publishing research work and conference paper related to such disorders. It is known that OMICS Group hosts over 700 edge peer reviewed Open Access Journals and organizes over more than 1000 Global Events annually. Its publishing group journals have over 5 million readers and the fame and success of the same can be attributed to the strong editorial board which contains over 75000+ eminent personalities that ensure a quality and quick review process checker.
Scope and Importance
Stress has been treated with a number of blockbuster drugs, but these have been severely impacted by patent expiration. At its peak in 2003, the branded depression drug market was worth almost $15 billion, but by 2012 the market had lost almost a third of its value, with sales of $9.560 billion reported that year. Consensus forecasts from Thomson Reuters Cortellis™ Competitive Intelligence anticipate an even steeper decline from 2013 to 2014, with 2014 forecast sales of $5.720 billion. The pharma companies have as yet been unable to produce new products that significantly differentiate themselves from generic formulations, resulting in the drop in market revenue
Relevant OMICS Conferences
In every single country we looked at, consumption of anti-depressants has risen since 2000. Antidepressants are still the most consumed class of medication in the U.S., with 270 million prescriptions per year. But sales revenue has gone down, to $9.4 billion, from a 2008 peak of $12 billion. Lower-priced generics now account for 85% of prescriptions, and 40% of the market in terms of revenue, with branded pharmaceutical companies withdrawing from the antidepressant market as their patents expire.Mental Health Projects receive funding from various foundations across the globe. Baxter International Foundation, Hogg foundation- USA, Bristol-Myers Squibb Foundation- USA, Irish Hospice Foundation- Belgium, De Overmolen- Ireland, Samusocial- Belgium are few of them. Major antidepressant producing industries i.e. Eli Lilly, AstraZeneca, Johnson & Johnson, Bristol-Meyers Squibb, GlaxoSmithKline and Pfizer etc. are investing and generating good revenues.
A normal physical response to events that make you feel threatened or upset your balance in some way is known as Stress. It has been seen that when you sense danger either imaginary or natural the body's defenses kick into high gear in a rapid and automatic process which is known as the “fight-or-flight-or-freeze” reaction. It is also known as Stress response. It should be noted that the stress response is the body’s way of protecting you. It helps you stay alert, focused and energetic whenever it is working properly. It should be noted that in emergency situations disorder of stress can save your life and may give you extra strength to defend yourself. It has been estimated that the stress response also helps you rise to meet challenges. It is Stress which keeps you on your toes during a presentation at work and sharpens your concentration when you’re attempting the game-winning free throw. It is stress which drives you to study for an exam when you'd rather be watching TV. However, above a certain threshold, stress act as disorder and stops being helpful and starts causing major damage to your health.
This page will be updated regularly.
This page was last updated on 11th Sep, 2015
1-702-508-5200 Ext:8031, 8041
1-702-508-5200 Ext:8045, 8047
Immunology & Microbiology Conferences
Nursing and Healthcare Conferences
Clinical and Biochemistry Conferences
1-702-508-5200 Ext:8031, 8037
Material Science Conferences
Genetics & Mol Biology Conferences
Media Partners | Advertising